Daratumumab for multiple myeloma

Children most at risk of over-reporting adherence to at-home chemotherapy regimen

Cancer-associated thrombosis: Switching patients to warfarin after 6-month completion of anticoagulant treatment

Study suggests warfarin is acceptable for long-term treatment of cancer-associated thrombosis

Researchers identify children most at risk of over-reporting adherence to at-home chemotherapy regimen

Research provides guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients

Promising new strategy for treating children with acute lymphocytic leukaemia

Comment: Whole exome sequencing finds genes associated with autoimmune platelet disorder in children

Comment: Classification system based on cytogenetics and treatment response identifies leukaemia patients with high-risk clinical features

Comment: Study identifies genetic variant that signifies higher risk for avascular necrosis in children with acute leukaemia

Comment: Genetic variants for increased risk of osteonecrosis in paediatric acute lymphocytic leukaemia identified

Engineered cells to target multiple myeloma